Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 218

1.

Changes in thymic function with age and during the treatment of HIV infection.

Douek DC, McFarland RD, Keiser PH, Gage EA, Massey JM, Haynes BF, Polis MA, Haase AT, Feinberg MB, Sullivan JL, Jamieson BD, Zack JA, Picker LJ, Koup RA.

Nature. 1998 Dec 17;396(6712):690-5.

PMID:
9872319
2.

Multiparameter evaluation of human thymic function: interpretations and caveats.

Harris JM, Hazenberg MD, Poulin JF, Higuera-Alhino D, Schmidt D, Gotway M, McCune JM.

Clin Immunol. 2005 May;115(2):138-46.

PMID:
15885636
3.

Evidence for thymic function in the elderly.

Douek DC, Koup RA.

Vaccine. 2000 Feb 25;18(16):1638-41. Review.

PMID:
10689141
4.

Restoration of the CD4 T cell compartment after long-term highly active antiretroviral therapy without phenotypical signs of accelerated immunological aging.

Vrisekoop N, van Gent R, de Boer AB, Otto SA, Borleffs JC, Steingrover R, Prins JM, Kuijpers TW, Wolfs TF, Geelen SP, Vulto I, Lansdorp P, Tesselaar K, Borghans JA, Miedema F.

J Immunol. 2008 Jul 15;181(2):1573-81.

5.

Endogenous IL-7 is associated with increased thymic volume in adult HIV-infected patients under highly active antiretroviral therapy.

Ruiz-Mateos E, de la Rosa R, Franco JM, Martinez-Moya M, Rubio A, Soriano N, Sanchez-Quijano A, Lissen E, Leal M.

AIDS. 2003 May 2;17(7):947-54.

PMID:
12700443
6.

Quantifying thymic export: combining models of naive T cell proliferation and TCR excision circle dynamics gives an explicit measure of thymic output.

Bains I, Thiébaut R, Yates AJ, Callard R.

J Immunol. 2009 Oct 1;183(7):4329-36. doi: 10.4049/jimmunol.0900743. Epub 2009 Sep 4.

7.

Early recovery of CD4+ T lymphocytes in children on highly active antiretroviral therapy. Dutch study group for children with HIV infections.

Cohen Stuart JW, Slieker WA, Rijkers GT, Noest A, Boucher CA, Suur MH, de Boer R, Geelen SP, Scherpbier HJ, Hartwig NG, Hooijkaas H, Roos MT, de Graeff-Meeder B, de Groot R.

AIDS. 1998 Nov 12;12(16):2155-9.

PMID:
9833856
8.

Evidence of thymic reconstitution after highly active antiretroviral therapy in HIV-1 infection.

Hardy G, Worrell S, Hayes P, Barnett CM, Glass D, Pido-Lopez J, Imami N, Aspinall R, Dutton J, Gazzard B, Peters AM, Gotch FM.

HIV Med. 2004 Mar;5(2):67-73.

9.

Immune reconstitution in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy: a cohort study.

Johnston AM, Valentine ME, Ottinger J, Baydo R, Gryszowka V, Vavro C, Weinhold K, St Clair M, McKinney RE.

Pediatr Infect Dis J. 2001 Oct;20(10):941-6.

PMID:
11642627
10.

T cell receptor excision circle (TREC) content following maximum HIV suppression is equivalent in HIV-infected and HIV-uninfected individuals.

Steffens CM, Smith KY, Landay A, Shott S, Truckenbrod A, Russert M, Al-Harthi L.

AIDS. 2001 Sep 28;15(14):1757-64.

PMID:
11579236
11.

Association between larger thymic size and higher thymic output in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy.

Kolte L, Dreves AM, Ersbøll AK, Strandberg C, Jeppesen DL, Nielsen JO, Ryder LP, Nielsen SD.

J Infect Dis. 2002 Jun 1;185(11):1578-85. Epub 2002 May 17.

12.

Quantification of thymic function by measuring T cell receptor excision circles within peripheral blood and lymphoid tissues in monkeys.

Sodora DL, Douek DC, Silvestri G, Montgomery L, Rosenzweig M, Igarashi T, Bernacky B, Johnson RP, Feinberg MB, Martin MA, Koup RA.

Eur J Immunol. 2000 Apr;30(4):1145-53.

13.
14.
15.

Comparison of thymic function-related markers to predict early CD4 T-cell repopulation in adult HIV-infected patients on HAART.

Ruiz-Mateos E, de la Rosa R, Soriano N, Martinez-Moya M, Rubio A, Sánchez-Quijano A, Lissen E, Leal M.

Antivir Ther. 2003 Aug;8(4):289-94.

PMID:
14518697
16.

Thymic activity in late-stage HIV-1 infected individuals receiving highly active antiretroviral therapy: potential effect of steroid therapy.

Pido-Lopez J, Pires A, Nelson M, O'Moore E, Fisher M, Gazzard B, Aspinall R, Gotch F, Imami N.

HIV Med. 2002 Jan;3(1):56-61.

17.

Analysis of telomere length and thymic output in fast and slow/non-progressors with HIV infection.

Richardson MW, Sverstiuk A, Hendel H, Cheung TW, Zagury JF, Rappaport J.

Biomed Pharmacother. 2000 Feb;54(1):21-31.

PMID:
10721459
18.

HIV-infected patients with a large thymus maintain higher CD4 counts in a 5-year follow-up study of patients treated with highly active antiretroviral therapy.

Kolte L, Ryder LP, Albrecht-Beste E, Jensen FK, Nielsen SD.

Scand J Immunol. 2009 Dec;70(6):608-13. doi: 10.1111/j.1365-3083.2009.02328.x.

19.

Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.

Verweel G, van Rossum AM, Hartwig NG, Wolfs TF, Scherpbier HJ, de Groot R.

Pediatrics. 2002 Feb;109(2):E25.

PMID:
11826235
20.

T-cell repopulation and thymic volume in HIV-1-infected adult patients after highly active antiretroviral therapy.

Franco JM, Rubio A, Martínez-Moya M, Leal M, Merchante E, Sánchez-Quijano A, Lissen E.

Blood. 2002 May 15;99(10):3702-6.

Items per page

Supplemental Content

Write to the Help Desk